Crinetics Pharmaceuticals (CRNX) Stock Chart & Stock Price History $37.35 +0.87 (+2.38%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Crinetics Pharmaceuticals Stock Price Performance 5 Day Performance-4.18%1 Month Performance-28.30%3 Month Performance-36.79%6 Month Performance-28.73%Year-To-Date Performance-26.95%1 Year Performance+3.18% Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CRNX Stock Chart for Saturday, January, 18, 2025 CRNX Chart by TradingView Crinetics Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$36.48$37.35+2.38%$37.96$36.79761,824 shs$3.46 billion01/16/2025$36.73$36.48-0.68%$37.29$35.921.60 million shs$3.38 billion01/15/2025$35.62$36.73+3.12%$37.42$35.761.65 million shs$3.41 billion01/14/2025$38.98$35.62-8.62%$39.53$35.511.91 million shs$3.30 billion01/13/2025$40.59$38.98-3.97%$40.98$38.061.90 million shs$3.61 billion01/10/2025$48.50$40.59-16.31%$47.56$40.043.03 million shs$3.76 billion Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/09/2025$48.50$48.50$49.41$48.02759,991 shs$4.50 billion01/08/2025$49.42$48.50-1.86%$49.41$48.02759,991 shs$4.50 billion01/07/2025$50.49$49.42-2.12%$51.06$49.11610,705 shs$4.58 billion01/06/2025$53.15$50.49-5.00%$53.41$50.31651,047 shs$4.68 billion01/03/2025$51.55$53.15+3.10%$53.55$51.60522,621 shs$4.93 billion01/02/2025$51.13$51.55+0.82%$52.51$51.09569,509 shs$4.78 billion01/01/2025$51.13$51.13$52.09$50.43523,105 shs$4.74 billion12/31/2024$50.67$51.13+0.91%$52.09$50.43523,105 shs$4.74 billion12/30/2024$51.85$50.67-2.28%$51.28$50.50420,244 shs$4.70 billion12/27/2024$53.92$51.85-3.84%$53.66$51.55381,466 shs$4.81 billion12/26/2024$53.94$53.92-0.04%$54.17$52.88391,715 shs$5.00 billion12/25/2024$53.94$53.94$54.78$53.15150,330 shs$5.00 billion12/24/2024$53.96$53.94-0.04%$54.78$53.15150,330 shs$5.00 billion12/23/2024$53.60$53.96+0.67%$54.09$52.47422,222 shs$5.00 billion12/20/2024$52.74$53.60+1.63%$54.25$51.731.94 million shs$4.97 billion12/19/2024$52.09$52.74+1.25%$53.04$50.811.12 million shs$4.89 billion12/18/2024$55.37$52.09-5.92%$55.47$51.351.16 million shs$4.83 billion12/17/2024$54.63$55.37+1.35%$56.15$53.041.03 million shs$5.13 billion Related Companies Viatris Stock Chart Intra-Cellular Therapies Stock Chart Summit Therapeutics Stock Chart Moderna Stock Chart Dr. Reddy's Laboratories Stock Chart Catalent Stock Chart Sarepta Therapeutics Stock Chart Qiagen Stock Chart Vaxcyte Stock Chart Ascendis Pharma A/S Stock Chart Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRNX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
